Disclosure: I am/we are long CRME, KHTRF, STDY. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose …
Seeking Alpha
Cardiome Pharma Corp (NASDAQ:CRME) (TSE:COM) has earned an average …
BNS3d
The consensus recommendation by Thomson Reuters analysts is Outperform and their mean rating for the stock is 1.83 on scale of 1-5. Cardiome Pharma Corp. (NASDAQ:CRME) announced that it has amended its term loan agreement with …
NYSE
Cardiome Pharma Corp. (CRME - Free Report) reported loss of 20 cents per share in first quarter of 2017. Reported loss is wider than both the Zacks Consensus Estimate of a loss of 15 cents and year-ago loss of 9 cents. The wider loss can …
Loss Wider
Cardiome Pharma (NASDAQ:CRME) headquartered in Vancouver, Canada, …
NASDAQ
Cardiome is traded on the NASDAQ Capital Market (CRME) and the Toronto Stock Exchange (COM). For more information, please visit our web site at www.cardiome.com.
CRG
Cardiome Pharma Corp.CRME was a big mover last session, as the company saw its shares rise a little above 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues …
Cardiome is traded on the NASDAQ Capital Market (CRME) and the Toronto Stock Exchange (COM). For more …
Agreement
A year ago, they were trading at $4.97. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CRME at https://www.zacks.com/ap/CRME
Stock market analysts and brokers have recently amended their target prices on shares of Cardiome Pharma Corporation (CRME). According to the latest research reports released, 1 analyst has issued a rating of “buy”, 5 analysts …